Inventor Of Enable IPC's Ultracapacitor Technology to Present at ISEE'Cap 09

Enable IPC Corporation (Pink Sheets: EIPC) announced that today Dr. Marc Anderson, a Professor at the Department of Civil and Environmental Engineering at the University of Wisconsin and one of the inventors of Enable IPC's ultracapacitor technology, will be presenting the technology at ISEE'Cap 09, the First Annual Symposium on Enhanced Electrochemical Capacitors in Nantes, France. The presentation, co-authored by Dr. Anderson and Kevin Leonard (the Chief Technology Officer of Enable IPC's SolRayo subsidiary), is entitled "Electrochemical Capacitors Using Novel Nanoporous Insulating Oxide Materials". The presentation will include some of the latest data on Enable IPC's ultracapacitor performance and potential applications.

Enable IPC CEO David Walker recently released an on-demand Webcast designed as a 5 minute introduction of the Company's management, subsidiary operation SolRayo and current projects and opportunities to interested individuals. Additionally, the Webcast provides a brief description of the Company's technologies:

  • A microbattery that provides greater power at less cost than competing technologies for use in "smart" cards
  • An ultracapacitor for use in consumer, transportation and industrial applications, including renewable energy

The Webcast is available now at: http://www.enableipc.com/presentations_intro.html and can be viewed at your convenience.

Enable IPC's Ultracapacitors Used in High Profile Renewable Energy Project

Enable IPC has recently completed ultracapacitor electrode shipments to IMDEA Energia in Madrid, Spain for a renewable energy demonstration project. The electrodes will be incorporated into a power conditioning unit by IMDEA and Green Power, a Spain-based renewable energy manufacturer, for a demonstration as part of the SA2VE project -- a Spanish government-sponsored program focused on new energy solutions, particularly relating to "green" power. If the project is successful, the Company will have a multi-million dollar opportunity in renewable energy.

The Company's ultracapacitor technology combines nanoparticles with common carbon sheets for a low cost, easy-to-implement process that improves the performance of ultracapacitors as clean energy storage devices. The enhanced ultracapacitors are simpler, cheaper and longer lasting than conventional devices, including some batteries, but perform just as well for many applications including renewable energy.

$600 Million Ultracapacitor Market

Enable IPC / SolRayo's ultracapacitor technology is aimed at a market estimated to grow to over $600 million by the year 2012. While the company has been mostly focusing on the use of ultracapacitors in renewable energy, there are also huge opportunities for this technology in consumer, other industrial and transportation applications as well.

Enable IPC provides efficient, streamlined strategies for turning technologies into products and bringing them to market. Enable IPC's growing portfolio currently includes the exclusive rights to two break-through energy technologies: a nanoparticle-based ultracapacitor and a nanowire-based microbattery.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Enable IPC. (2019, March 19). Inventor Of Enable IPC's Ultracapacitor Technology to Present at ISEE'Cap 09. AZoNano. Retrieved on April 16, 2024 from https://www.azonano.com/news.aspx?newsID=12331.

  • MLA

    Enable IPC. "Inventor Of Enable IPC's Ultracapacitor Technology to Present at ISEE'Cap 09". AZoNano. 16 April 2024. <https://www.azonano.com/news.aspx?newsID=12331>.

  • Chicago

    Enable IPC. "Inventor Of Enable IPC's Ultracapacitor Technology to Present at ISEE'Cap 09". AZoNano. https://www.azonano.com/news.aspx?newsID=12331. (accessed April 16, 2024).

  • Harvard

    Enable IPC. 2019. Inventor Of Enable IPC's Ultracapacitor Technology to Present at ISEE'Cap 09. AZoNano, viewed 16 April 2024, https://www.azonano.com/news.aspx?newsID=12331.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.